BMY - Bristol Myers lung cancer drug Krazati succeeds in late-stage trial
2024-06-01 08:53:44 ET
More on Bristol-Myers Squibb Company
- Bristol Myers Squibb: 5.5% Yielder Has Been Crushed In What Could Be A Generational Buying Opportunity
- Bristol-Myers Squibb Company (BMY) Bank of America Global Healthcare Conference 2024 Transcript
- Bristol-Myers Squibb Company (BMY) Presents at Guggenheim Securities Radiopharmaceuticals Day (Transcript)
- Bristol Myers' Breyanzi gains additional indication for mantle cell lymphoma
- Bristol-Myers gets EU approval for Opdivo for bladder cancer